REIMBURSEMENT

TASK FORCE

Overview

The purpose of the DPA Reimbursement Task Force is to support the market access of digital pathology solutions globally and drive the value of whole slide imaging (WSI) and AI-based algorithms. The key objectives of the task force are:

Drive and shape the model for reimbursement for WSI and AI-based image analysis
Support increased market access for DP solutions globally
Be the trusted resource (single point of contact) for reimbursement/market access issues for digital pathology
Create uniformity in communication around reimbursement for digital pathology solutions
Map the reimbursement environment globally and set the strategy for DPA influence

Participation in this Task Force is open to Benefactor member representatives only.

DPA Staff Manager

Megan Bain: mbain@digitalpathologyassociation.org

Co-Chairs

Jennifer Archer, MPP

Senior Director of Market Access

Artera

Michael Rivers

Vice President & General Manager, Mountain View
Roche Tissue Diagnostics

Committee Members

Melissa Alexander, MD, PhD, FCAP, AstraZeneca
Jennifer Archer, MPP, Artera
Amruta Ashtekar, Daiichi Sankyo, Inc.
Scott Blakely, Hamamatsu Corporation
Nathan Buchbinder, Proscia Inc.
Dawn Cardeiro, MS, Roche
Joseph Chiweshe, MD MPH, Leica Biosystems
Amanda Coble, PA ASCP, Proscia Inc.
Rahul Dhanda, Agilent Technologies
Dana Dilbeck, Agilent Technologies
Deeksha Dua, Philips
Ben Glass, PathAI
Michael Hartevelt, Merck
David Klimstra, MD, Yale University School of Medicine
Amanda Lowe, Artera
John Memarian, PA, MSc, CitiusTech
Mischa Nelis, Philips
Anil Parwani, MD, PhD, MBA, Ohio State University Wexner Medical Center
Nicole Ramsey, Merck
Scott Randall, Hamamatsu Corporation
Michael Rivers, Roche
Elizabeth Sheppard, HT(ASCP), MBA, AstraZeneca
Angela Stewart, Leica Biosystems
Sarah Thibault-Sennett, Hologic, Inc.
Jay Tolley, Mayo Clinic Platform
Michelle Wynn, Hologic, Inc.

Chat bot